Terms: = Kidney tumors AND GATA1, ERYF1, P15976, 2623, ENSG00000102145, NFE1, GF1
9 results:
1. Differential expression profiling of onco and tumor-suppressor genes from major-signaling pathways in Wilms' tumor.
Sahu DK; Singh N; Das M; Rawat J; Gupta DK
Pediatr Surg Int; 2022 Nov; 38(11):1601-1617. PubMed ID: 36107237
[TBL] [Abstract] [Full Text] [Related]
2. Innate immune checkpoint Siglec10 in cancers: mining of comprehensive omics data and validation in patient samples.
Zhang C; Zhang J; Liang F; Guo H; Gao S; Yang F; Guo H; Wang G; Wang W; Zhou G
Front Med; 2022 Aug; 16(4):596-609. PubMed ID: 35075579
[TBL] [Abstract] [Full Text] [Related]
3. Feedback activation of gata1/miR-885-5p/PLIN3 pathway decreases sunitinib sensitivity in clear cell renal cell carcinoma.
Yao D; Xia S; Jin C; Zhao W; Lan W; Liu Z; Xiu Y
Cell Cycle; 2020 Sep; 19(17):2195-2206. PubMed ID: 32783497
[TBL] [Abstract] [Full Text] [Related]
4. Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go.
Lai TC; Ma WK; Yiu MK
Hong Kong Med J; 2016 Feb; 22(1):39-45. PubMed ID: 26492927
[TBL] [Abstract] [Full Text] [Related]
5. Decreased mRNA expression of gata1 and GATA2 is associated with tumor aggressiveness and poor outcome in clear cell renal cell carcinoma.
Peters I; Dubrowinskaja N; Tezval H; Kramer MW; von Klot CA; Hennenlotter J; Stenzl A; Scherer R; Kuczyk MA; Serth J
Target Oncol; 2015 Jun; 10(2):267-75. PubMed ID: 25230694
[TBL] [Abstract] [Full Text] [Related]
6. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.
Eisermann K; Tandon S; Bazarov A; Brett A; Fraizer G; Piontkivska H
BMC Genomics; 2008 Jul; 9():337. PubMed ID: 18631392
[TBL] [Abstract] [Full Text] [Related]
7. Experimental pretargeting studies of cancer with a humanized anti-CEA x murine anti-[In-DTPA] bispecific antibody construct and a (99m)Tc-/(188)Re-labeled peptide.
Karacay H; McBride WJ; Griffiths GL; Sharkey RM; Barbet J; Hansen HJ; Goldenberg DM
Bioconjug Chem; 2000; 11(6):842-54. PubMed ID: 11087333
[TBL] [Abstract] [Full Text] [Related]
8. GATA-1 transactivates the WT1 hematopoietic specific enhancer.
Wu Y; Fraizer GC; Saunders GF
J Biol Chem; 1995 Mar; 270(11):5944-9. PubMed ID: 7890725
[TBL] [Abstract] [Full Text] [Related]
9. Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case.
Shipley JM; Birdsall S; Clark J; Crew J; Gill S; Linehan M; Gnarra J; Fisher S; Craig IW; Cooper CS
Cytogenet Cell Genet; 1995; 71(3):280-4. PubMed ID: 7587394
[TBL] [Abstract] [Full Text] [Related]
